← Back to Patent Explorer
US4295567A Expired / Lapsed US ⏱️ 0.0 years remaining

Medicament container

Assignee: Beecham Group PLC
•
Filing: 1979-11-09
•
Granted: 1981-10-20
•
Expires: 1999-11-09
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A pharmaceutical dispensing container which holds two dosage units which are symptomatic treatment for respiratory tract disorders, the first of these dosage units being indicated for day-time administration and being non-sedative and the second of these dosage units being indicated for night-time administration and being sedative. Indication means include the dosage units being in register with a time chart and a distinguishing visible feature of the dosage units.

Inventors

  • 👤 Eric T. Knudsen

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 19:37
CPC Classifications
A; A61; A61J; A61J7/00; A61J7/04; A61J1/00; A61J1/03; A61J1/035

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 59 words
A pharmaceutical dispensing container, which contains two dosage units which are symptomatic treatments for respiratory tract disorders, the first of these dosage units being non-sedative, and the second of these dosage units being sedative, and an indicia for distinguishing between said first and second dosage units is provided on at least one of the container and said dosage units.
Claim 2
Dependent Claim 59 words
A pharmaceutical dispensing container, which contains two dosage units which are symptomatic treatments for respiratory tract disorders, the first of these dosage units being non-sedative, and the second of these dosage units being sedative, and an indicia for distinguishing between said first and second dosage units is provided on at least one of the container and said dosage units.
Claim 3
Dependent Claim 43 words
A container according to claim 1, wherein the first of the dosage units is indicated for daytime administration and the second is indicated for night-time administration by means of the dosage units being housed in the container in register with a time chart.
Claim 4
Dependent Claim 20 words
A container according to claim 1, wherein the first and second dosage units are mutually distinguished by a visible feature.
Claim 5
Dependent Claim 16 words
A container according to claim 1, which container is in the form of a blister pack.
Claim 6
Dependent Claim 14 words
A container according to, claim 1 wherein the dosage units are soft gelatin capsules.
Claim 7
Dependent Claim 12 words
A container according to claim 5, wherein the capsules are visually distingishable.
Claim 8
Independent Claim 71 words
A method of treating respiratory tract infections, which comprises administering during the daytime at least one dosage unit of a non-sedative composition for symptomatic treatment of respiratory tract disorders in combination with administering during the nighttime at least one dosage unit of a sedative composition for symptomatic treatment of respiratory tract disorders, said non-sedative composition being administered only during the daytime and said sedative composition being administered only during the nighttime.
Claim 9
Independent Claim 71 words
A method of treating respiratory tract infections, which comprises administering during the daytime at least one dosage unit of a non-sedative composition for symptomatic treatment of respiratory tract disorders in combination with administering during the nighttime at least one dosage unit of a sedative composition for symptomatic treatment of respiratory tract disorders, said non-sedative composition being administered only during the daytime and said sedative composition being administered only during the nighttime.
Claim 10
Dependent Claim 16 words
The method according to claim 7 wherein said non-sedative composition comprises an antitussive and a decongestant.
Claim 11
Dependent Claim 18 words
The method according to claim 7 wherein said sedative composition comprises an antitussive, a decongestant and an antihistamine.

References Cited (Backward Citations)

US3324995A Cited
US3305077A Cited
US3397671A Cited
US3537422A Cited
US3515265A Cited
US3757441A Cited
US3780856A Cited
US4039080A Cited
US4038937A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-10-19 1985-04-20 1985-10-20 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-10-19 1989-04-20 1989-10-20 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-10-19 1993-04-20 1993-10-20 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag